Ketorolac Tromethamine Injection, Solution
Product Images NDC 51662-1292

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 51662-1292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mL Vial (1008010 0409 3795 19 Ketorolac Vial)

Label for Ketorolac Tromethamine injection, USP 30 mg/mL, 1 mL single-dose vial. The label indicates it is for intravenous or intramuscular use and is Rx only. Manufactured by Hospira, Inc., Lake Forest, IL, USA. NDC 0409-3795-19 is displayed.*

FDA Label Image

Vial (1008040 0409 3796 19 Ketorolac Vial)

Label for Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL) single-dose vial. The label specifies 2 mL fill for intramuscular use only, includes the NDC code 0409-3796-19, and is marked Rx only. Manufactured by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

51662129227 Ketorolac Pouch Label

Label for KETOROLAC TROMETHAMINE injection solution USP 30 mg/mL in a 1 mL vial. The label includes NDC 51662-1292-2, lot number 12345, and expiration date 2030-06-30. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label states it is for intravenous/intramuscular use and storage instructions at 20 to 25°C.*

FDA Label Image

51662129234 Ketorolac Case Label

Label for KETOROLAC TROMETHAMINE injection, USP 30 mg/mL, 1 mL vial, box of 25. Includes NDC 51662-1292-3, lot number 12345, and expiration date 2030-06-30. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

51662129234 Ketorolac Rfid Label

A gray and white pharmaceutical label showing a GS1 DataMatrix barcode and human-readable identifiers. The label includes a GTIN number, expiration date, lot number, and instructions to see the manufacturer's package insert. It also lists the distributor as HF Acquisition Co., LLC, Mukilteo, WA 98275. The label is for a prescription drug but does not show proprietary name, strength, or dosage form on this visible portion.*

FDA Label Image

5166212952 Label

Label for KETOROLAC TROMETHAMINE 60 mg/2 mL vial injection solution for intramuscular use. The label includes the NDC code 51662-1295-2, lot number placeholder letters, and an expiration date of 2021-06-01. It indicates storage conditions and that the product is distributed by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA.*

FDA Label Image

5166212953 Rfid Label

A small white label featuring a GS1 DataMatrix barcode and human-readable alphanumeric codes commonly used for product serialization and traceability. The text references distribution by HF Acquisition Co., LLC, Mukilteo, WA. The label notes to see the manufacturer's package insert and includes the phrase 'RX ONLY' on the side.*

FDA Label Image

5166212953 Label

Label for KETOROLAC TROMETHAMINE 60 mg/2 mL injection solution vial, box of 25, indicated for intramuscular use. The label includes NDC 51662-1295-3, a sample lot number, expiration date 2021-06-01, and storage instructions. Distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*

FDA Label Image

Tabel 1 (Adverse 1)

A data table listing potential gastrointestinal and other experiences associated with the drug, including abdominal pain, constipation/diarrhea, dyspepsia, flatulence, gastrointestinal fullness and ulcers, gross bleeding/perforation, heartburn, nausea, stomatitis, vomiting, abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating.*

FDA Label Image

Tabel 2 (Adverse 2)

A data table showing percentages of adult patients divided by age groups (<65 years and ≥65 years) and total daily dose ranges of Ketorolac Tromethamine Injection. The table is split into two sections: patients without history of PUB and patients with history of PUB, with corresponding percentage values for each dose category.*

FDA Label Image

Boxed Warning (Boxed Warning)

This image shows a drug warning information panel for Ketorolac Tromethamine Injection. It details contraindications, gastrointestinal and cardiovascular risks, renal risk, bleeding risk, hypersensitivity reactions, administration restrictions, risk during labor, concomitant NSAID use, special population dosage adjustments, and information on ketorolac tromethamine tablets dosage and administration.*

FDA Label Image

Tabel 1 (Clinical Pharma Tabel 1)

A pharmacokinetic parameters table comparing oral, intramuscular, and intravenous bolus administration of Ketorolac Tromethamine at various dosages. It includes values for Tmax, Cmax, Cmin, and Cavg plasma concentrations, volume of distribution, metabolism, excretion, and protein binding percentages from studies with normal volunteers. Footnotes explain data sources and notations.*

FDA Label Image

Tabel 2 (Clinical Tabel 2)

A data table presenting pharmacokinetic parameters for Ketorolac Tromethamine, comparing total clearance and terminal half-life values for intramuscular and oral routes across different subject groups including normal subjects, healthy elderly subjects, patients with hepatic dysfunction, patients with renal impairment, and renal dialysis patients. The table includes mean values and ranges for each group and administration method.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

Tabel (How Supplied)

A data table listing NDC numbers, unit of sale, concentration, fill volume/container size, and total ketorolac tromethamine per container for Ketorolac Tromethamine injection solution. It shows various vial strengths and volumes, including 15 mg and 30 mg strengths in 2 mL glass fliptop vials, and a 60 mg strength with 2 mL fill volume, sold in trays of 25.*

FDA Label Image

Logo (Med Guide Logo)

FDA Label Image

Logo (Spl Logo)

FDA Label Image

1 mL Serialized Label (Serialized 51662 1292 1 Ketorolac 1ml)

KETOROLAC TROMETHAMINE injection, solution in a 1 mL single-dose amber glass vial with a white cap. The label states 30 mg/mL strength for intramuscular and intravenous use. Distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Serialized Label (Serialized 51662 1295 1 Ketorolac 2ml Vial)

KETOROLAC TROMETHAMINE 60 mg/2 mL injection solution in a dark brown glass vial with a purple cap. The vial label includes the brand and generic names, strength, and administration route as intramuscular (IM or I.M.). A white secondary label with barcodes and distributor information from HF Acquisition Co., LLC in Mukilteo, WA is attached.*

FDA Label Image

Structure (Structure Desc)

Chemical structure of ketorolac tromethamine showing the molecular arrangement of both ketorolac and tromethamine components with their associated molecular formulas (C15H13NO3 and C4H11NO3).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.